Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
The Methodist Hospital System has 3 pending office actions in the Medical Devices & Mechanical Engineering technology area. These actions are assigned to 3 distinct examiners across 2 distinct art units. This indicates that each pending matter is being reviewed by a different official, which prevents any single examiner's habits from dominating the portfolio's overall progress. The involvement of 2 distinct art units suggests the applications cover at least 2 different technical sub-specialties within the broader medical device field.
CESARE, JOSEPH DAVID is the busiest examiner with 1 pending office action. Given that there are 3 pending actions and 3 distinct examiners, the workload is evenly distributed among the assigned officials. This distribution means that the company must navigate the individual preferences of 3 different examiners while also managing filings in 2 separate art units. The concentration in 2 art units rather than 3 indicates that at least 2 of the 3 pending actions share a similar technical classification, even if they are handled by different examiners.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| §103 only | 1 (33%) |
| §112 only | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CESARE, JOSEPH DAVID | 1 | — | — |
| SISON, CHRISTINE ANDREA PAN | 1 | 33.3% | +37.7% |
| WANG, CHANG YU | 1 | 33.5% | +53.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18566129 | DKK1/HLA-A2 BINDING MOLECULES AND METHODS OF THEIR USE | CESARE, JOSEPH DAVID | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18288019 | SYSTEMS AND METHODS FOR IMPROVING CEREBROSPINAL FLUID (CSF) DRAINAGE | SISON, CHRISTINE ANDREA PAN | — |
| 18020502 | BECLIN 2 AND USES THEREOF FOR TREATING CANCER AND NEURODEGENERATIVE DISEASES | WANG, CHANG YU | — |
| Art Unit | Apps |
|---|---|
| 3700 | 1 |
| 1675 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18566129 | DKK1/HLA-A2 BINDING MOLECULES AND METHODS OF THEIR USE | CESARE, JOSEPH DAVID | — | §101§102§103§112Other | Non-Final OA | — | Pending | Dec 01, 2023 |
| 18288019 | SYSTEMS AND METHODS FOR IMPROVING CEREBROSPINAL FLUID (CSF) DRAINAGE | SISON, CHRISTINE ANDREA PAN | 3700 | §103 | Final Rejection | — | Pending | Oct 23, 2023 |
| 18020502 | BECLIN 2 AND USES THEREOF FOR TREATING CANCER AND NEURODEGENERATIVE DISEASES | WANG, CHANG YU | 1675 | §112 | Final Rejection | — | Pending | Feb 09, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial